Repros Therapeutics Inc. News Headlines

RPRX 
$9.15
*  
0.285
3.21%
Get RPRX Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading RPRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Repros Provides Proellex Update - Analyst Blog
3/18/2014 4:10:01 PM - Zacks.com


Narrower-than-Expected Q4 Loss at Repros - Analyst Blog
3/14/2014 8:50:01 AM - Zacks.com


Data on Repros' Androxal - Analyst Blog
2/11/2014 6:26:01 PM - Zacks.com


Repros Therapeutics (RPRX) Jumps: Stock Rises 6.1% - Tale of the Tape
2/10/2014 9:46:01 AM - Zacks.com


Repros Shares Soar After FDA Meeting - Analyst Blog
2/7/2014 10:27:01 AM - Zacks.com


Can the Rally in Repros Therapeutics (RPRX) Shares Continue? - Tale of the Tape
1/16/2014 6:43:01 AM - Zacks.com


Repros Continues to Gain on Androxal News - Analyst Blog
1/13/2014 5:00:01 PM - Zacks.com


Loss Narrows at Repros, Shares Down - Analyst Blog
11/11/2013 11:50:01 AM - Zacks.com


Update on Repros' Pipeline - Analyst Blog
11/6/2013 7:05:24 PM - Zacks.com


Androxal Makes Repros A Buy
11/2/2013 7:08:00 AM - Seeking Alpha


Insiders Buy Shares at Helix Energy and SunTrust Banks While Ruby Tuesday Sees a Sale
10/28/2013 8:50:00 AM - Minyanville


Update on Repros' Androxal - Analyst Blog
10/25/2013 5:07:15 PM - Zacks.com


Repros Continues to Climb - Analyst Blog
9/23/2013 3:45:01 PM - Zacks.com


Repros Climbs on Positive Androxal Data - Analyst Blog
9/18/2013 11:10:01 AM - Zacks.com


Market Wrap for Tuesday, September 17: Metals All Down, Repros Therapeutics Gives Back Mostly All Gains
9/17/2013 3:15:50 PM - Benzinga


Mid-Afternoon Market Update: Markets Topping Out as Berry Plastics Gets Crushed on Poor Guidance
9/17/2013 2:40:16 PM - Benzinga


Repros Therapeutics: Winning The Battle But Losing The War?
9/17/2013 8:52:00 AM - Seeking Alpha


Approval In Peyronie's Only Part Of The Auxilium Story
8/27/2013 10:21:00 AM - Seeking Alpha


Repros Reports Androxal Interim Data - Analyst Blog
8/21/2013 4:20:01 PM - Zacks.com


Loss Widens at Repros in Q2 - Analyst Blog
8/13/2013 9:45:01 AM - Zacks.com


Healthcare Stocks Tumble; Repros Therapeutics Prices Upsized $72-Mln Stock Offering
6/20/2013 2:54:41 PM - MT Newswires


Sector Update: Healthcare
6/20/2013 2:46:33 PM - MT Newswires


The Key To Creating Large Gains: Patience
6/4/2013 6:55:00 AM - Seeking Alpha


Repros to Conduct Phase IIb Trial - Analyst Blog
5/23/2013 5:30:20 PM - Zacks.com


Investor sticks with winner in Repros
5/1/2013 3:46:42 AM - optionMONSTER